Montag & Associates’s Quest Diagnostics DGX Stock Holding History

Montag & Associates’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$186K	Hold	950	–	–	0.01%	432
2025 Q4	$165K	Hold	950	–	–	0.01%	433
2025 Q3	$181K	Hold	950	–	–	0.01%	412
2025 Q2	$171K	Hold	950	–	–	0.01%	420
2025 Q1	$161K	Hold	950	–	–	0.01%	434
2024 Q4	$143K	Hold	950	–	–	0.01%	460
2024 Q3	$147K	Hold	950	–	–	0.01%	459
2024 Q2	$130K	Hold	950	–	–	0.01%	461
2024 Q1	$126K	Hold	950	–	–	0.01%	462
2023 Q4	$131K	Hold	950	–	–	0.01%	445
2023 Q3	$116K	Hold	950	–	–	0.01%	445
2023 Q2	$134K	Hold	950	–	–	0.01%	443
2023 Q1	$134K	Hold	950	–	–	0.01%	434
2022 Q4	$149K	Hold	950	–	–	0.01%	411
2022 Q3	$117K	Hold	950	–	–	0.01%	421
2022 Q2	$126K	Hold	950	–	–	0.01%	417
2022 Q1	$130K	Hold	950	–	–	0.01%	432
2021 Q4	$164K	Hold	950	–	–	0.01%	412
2021 Q3	$138K	Hold	950	–	–	0.01%	434
2021 Q2	$125K	Hold	950	–	–	0.01%	444
2021 Q1	$122K	Hold	950	–	–	0.01%	448
2020 Q4	$113K	Buy	+950	New	+$116K	0.01%	439

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Montag & Associates's DGX Position: Q1 2026 in Review

Montag & Associates held its Quest Diagnostics (DGX) position steady in Q1 2026 at 950 shares worth $186K. The position accounts for 0.01% of the portfolio, ranked #432.

Montag & Associates first reported a position in DGX in Q4 2020 and has held it in 22 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Montag & Associates held 950 shares of Quest Diagnostics worth $186K as of Q1 2026.
Montag & Associates left its Quest Diagnostics share count unchanged in Q1 2026.
Quest Diagnostics made up 0.01% of Montag & Associates's portfolio in Q1 2026, its #432 holding.
Montag & Associates first reported a position in Quest Diagnostics in Q4 2020 and has held it in 22 quarters since.
1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.